{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:53:07Z","timestamp":1779195187698,"version":"3.51.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12015-024-10765-9","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T09:01:57Z","timestamp":1721293317000},"page":"1671-1691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Application of Mesenchymal Stem Cells in Different Cardiovascular Disorders: Ways of Administration, and the Effectors"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8915-4900","authenticated-orcid":false,"given":"Kemal","family":"Yuce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"issue":"10","key":"10765_CR1","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/sctm.16-0484","volume":"6","author":"M Majka","year":"2017","unstructured":"Majka, M., Su\u0142kowski, M., Badyra, B., & Musia\u0142ek, P. (2017). Concise Review: Mesenchymal stem cells in Cardiovascular Regeneration: Emerging research directions and clinical applications. Stem Cells Transl Med, 6(10), 1859\u20131867. https:\/\/doi.org\/10.1002\/sctm.16-0484","journal-title":"Stem Cells Transl Med"},{"issue":"5B","key":"10765_CR2","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/j.1582-4934.2008.00457.x","volume":"12","author":"C Nesselmann","year":"2008","unstructured":"Nesselmann, C., Ma, N., Bieback, K., Wagner, W., Ho, A., Konttinen, Y. T., Zhang, H., Hinescu, M. E., & Steinhoff, G. (2008). Mesenchymal stem cells and cardiac repair. Journal of Cellular and Molecular Medicine, 12(5B), 1795\u20131810. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00457.x","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"10765_CR3","doi-asserted-by":"publisher","first-page":"e9252","DOI":"10.1371\/journal.pone.0009252","volume":"5","author":"J Maggini","year":"2010","unstructured":"Maggini, J., Mirkin, G., Bognanni, I., Holmberg, J., Piazzon, I. M., Nepomnaschy, I., Costa, H., Canones, C., Raiden, S., Vermeulen, M., & Geffner, J. R. (2010). Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One, 5(2), e9252. https:\/\/doi.org\/10.1371\/journal.pone.0009252","journal-title":"PLoS One"},{"key":"10765_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2025","author":"F Diomede","year":"2023","unstructured":"Diomede, F., Guarnieri, S., Lanuti, P., Konstantinidou, F., Gatta, V., Rajan, T. S., Pierdomenico, S. D., Trubiani, O., Marconi, G. D., & Pizzicannella, J. (2023). Extracellular vesicles (EVs): A promising therapeutic tool in the heart tissue regeneration. Biofactors (Oxford, England). https:\/\/doi.org\/10.1002\/biof.2025","journal-title":"Biofactors (Oxford, England)"},{"key":"10765_CR5","doi-asserted-by":"publisher","first-page":"114817","DOI":"10.1016\/j.biopha.2023.114817","volume":"163","author":"Y Pan","year":"2023","unstructured":"Pan, Y., Wu, W., Jiang, X., & Liu, Y. (2023). Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: From mechanisms to therapy. Biomedicine & Pharmacotherapy, 163, 114817. https:\/\/doi.org\/10.1016\/j.biopha.2023.114817","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"10765_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","volume":"143","author":"A Bronckaers","year":"2014","unstructured":"Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., & Lambrichts, I. (2014). Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacology & Therapeutics, 143(2), 181\u2013196. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.02.013","journal-title":"Pharmacology & Therapeutics"},{"issue":"10","key":"10765_CR7","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/sctm.16-0484","volume":"6","author":"M Majka","year":"2017","unstructured":"Majka, M., Sulkowski, M., Badyra, B., & Musialek, P. (2017). Concise Review: Mesenchymal stem cells in Cardiovascular Regeneration: Emerging research directions and clinical applications. Stem Cells Transl Med, 6(10), 1859\u20131867. https:\/\/doi.org\/10.1002\/sctm.16-0484","journal-title":"Stem Cells Transl Med"},{"key":"10765_CR8","doi-asserted-by":"publisher","unstructured":"Tran, T., Cruz, C., Chan, A., Awad, S., Rajasingh, J., Deth, R., & Gurusamy, N. (2023). Mesenchymal stem cell-derived long noncoding RNAs in Cardiac Injury and Repair. Cells, 12(18). https:\/\/doi.org\/10.3390\/cells12182268","DOI":"10.3390\/cells12182268"},{"issue":"5","key":"10765_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s12265-012-9378-3","volume":"5","author":"NG Campbell","year":"2012","unstructured":"Campbell, N. G., & Suzuki, K. (2012). Cell delivery routes for stem cell therapy to the heart: Current and future approaches. Journal of Cardiovascular Translational Research, 5(5), 713\u2013726. https:\/\/doi.org\/10.1007\/s12265-012-9378-3","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"10765_CR10","doi-asserted-by":"publisher","unstructured":"Schuleri, K. H., Boyle, A. J., & Hare, J. M. (2007). Mesenchymal stem cells for Cardiac Regenerative Therapy. In K. Kauser, & A. M. Zeiher (Eds.), Bone marrow-derived progenitors (pp. 195\u2013218). Springer. https:\/\/doi.org\/10.1007\/978-3-540-68976-8_9","DOI":"10.1007\/978-3-540-68976-8_9"},{"issue":"8","key":"10765_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCRESAHA.111.243147","volume":"109","author":"AR Williams","year":"2011","unstructured":"Williams, A. R., & Hare, J. M. (2011). Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res, 109(8), 923\u2013940. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.243147","journal-title":"Circ Res"},{"issue":"13\u201314","key":"10765_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.lfs.2008.07.020","volume":"83","author":"SL Hale","year":"2008","unstructured":"Hale, S. L., Dai, W., Dow, J. S., & Kloner, R. A. (2008). Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: A quantitative assessment. Life Sciences, 83(13\u201314), 511\u2013515. https:\/\/doi.org\/10.1016\/j.lfs.2008.07.020","journal-title":"Life Sciences"},{"issue":"1","key":"10765_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5507\/bp.2018.071","volume":"163","author":"M Brychtova","year":"2019","unstructured":"Brychtova, M., Thiele, J. A., Lysak, D., Holubova, M., Kralickova, M., & Vistejnova, L. (2019). Mesenchymal stem cells as the near future of cardiology medicine - truth or wish? Biomedical Papers of the Medical Faculty of the University Palack\u00ef\u00bf\u00bd, Olomouc, Czechoslovakia, 163(1), 8\u201318. https:\/\/doi.org\/10.5507\/bp.2018.071","journal-title":"Biomedical Papers of the Medical Faculty of the University Palack\u00ef\u00bf\u00bd, Olomouc, Czechoslovakia"},{"key":"10765_CR14","doi-asserted-by":"publisher","first-page":"173049","DOI":"10.1016\/j.ejphar.2020.173049","volume":"876","author":"Z Liu","year":"2020","unstructured":"Liu, Z., Mikrani, R., Zubair, H. M., Taleb, A., Naveed, M., Baig, M., Zhang, Q., Li, C., Habib, M., Cui, X., Sembatya, K. R., Lei, H., & Zhou, X. (2020). Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations. European Journal of Pharmacology, 876, 173049. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173049","journal-title":"European Journal of Pharmacology"},{"key":"10765_CR15","doi-asserted-by":"publisher","unstructured":"Ishikawa, K. (2015). Intracoronary injection of large stem cells: Size matters. Circulation. Cardiovascular Interventions, 8(5). https:\/\/doi.org\/10.1161\/circinterventions.115.002648","DOI":"10.1161\/circinterventions.115.002648"},{"issue":"4","key":"10765_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12265-013-9479-7","volume":"6","author":"K Ishikawa","year":"2013","unstructured":"Ishikawa, K., Aguero, J., Naim, C., Fish, K., & Hajjar, R. J. (2013). Percutaneous approaches for efficient cardiac gene delivery. Journal of Cardiovascular Translational Research, 6(4), 649\u2013659. https:\/\/doi.org\/10.1007\/s12265-013-9479-7","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"6","key":"10765_CR17","doi-asserted-by":"publisher","first-page":"H2995","DOI":"10.1152\/ajpheart.00703.2004","volume":"288","author":"M Hayase","year":"2005","unstructured":"Hayase, M., Del Monte, F., Kawase, Y., Macneill, B. D., McGregor, J., Yoneyama, R., Hoshino, K., Tsuji, T., De Grand, A. M., Gwathmey, J. K., Frangioni, J. V., & Hajjar, R. J. (2005). Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. American Journal of Physiology Heart and Circulatory Physiology, 288(6), H2995\u20133000. https:\/\/doi.org\/10.1152\/ajpheart.00703.2004","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"issue":"10","key":"10765_CR18","doi-asserted-by":"publisher","first-page":"16904","DOI":"10.1002\/jcp.28381","volume":"234","author":"SM Parizadeh","year":"2019","unstructured":"Parizadeh, S. M., Jafarzadeh-Esfehani, R., Ghandehari, M., Parizadeh, M. R., Ferns, G. A., Avan, A., & Hassanian, S. M. (2019). Stem cell therapy: A novel approach for myocardial infarction. Journal of Cellular Physiology, 234(10), 16904\u201316912. https:\/\/doi.org\/10.1002\/jcp.28381","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10765_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ultrasmedbio.2015.09.010","volume":"42","author":"QW Sun","year":"2016","unstructured":"Sun, Q. W., Zhen, L., Wang, Q., Sun, Y., Yang, J., Li, Y. J., Li, R. J., Ma, N., Li, Z. A., Wang, L. Y., Nie, S. P., & Yang, Y. (2016). Assessment of Retrograde coronary venous infusion of mesenchymal stem cells combined with basic fibroblast growth factor in Canine myocardial infarction using strain values derived from Speckle-Tracking Echocardiography. Ultrasound in Medicine and Biology, 42(1), 272\u2013281. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2015.09.010","journal-title":"Ultrasound in Medicine and Biology"},{"issue":"6","key":"10765_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.healun.2014.03.006","volume":"33","author":"L Zakharova","year":"2014","unstructured":"Zakharova, L., Nural-Guvener, H., Feehery, L., Popovic, S., Nimlos, J., & Gaballa, M. A. (2014). Retrograde coronary vein infusion of cardiac explant-derived c-Kit\u2009+\u2009cells improves function in ischemic heart failure. Journal of Heart and Lung Transplantation, 33(6), 644\u2013653. https:\/\/doi.org\/10.1016\/j.healun.2014.03.006","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"6","key":"10765_CR21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/sctm.16-0331","volume":"6","author":"M Bervar","year":"2017","unstructured":"Bervar, M., Kozelj, M., Poglajen, G., Sever, M., Zemljic, G., Frljak, S., Cukjati, M., Cernelc, P., Haddad, F., & Vrtovec, B. (2017). Effects of Transendocardial CD34(+) cell transplantation on diastolic parameters in patients with nonischemic dilated cardiomyopathy. Stem Cells Transl Med, 6(6), 1515\u20131521. https:\/\/doi.org\/10.1002\/sctm.16-0331","journal-title":"Stem Cells Transl Med"},{"issue":"22","key":"10765_CR22","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., Breton, E., Davis-Sproul, J., Schulman, I. H., Byrnes, J., Mendizabal, A. M., Lowery, M. H., Rouy, D., Altman, P., Foo, W. P., Ruiz, C., Amador, P., Da Silva, A., McNiece, J., Heldman, I. K., George, A. W., R., & Lardo, A. (2012). Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. Journal of the American Medical Association, 308(22), 2369\u20132379. https:\/\/doi.org\/10.1001\/jama.2012.25321","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10765_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman, A. W., DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., Lopera, G., Miki, R., Willens, H., Hendel, R., Mitrani, R., Pattany, P., Feigenbaum, G., Oskouei, B., Byrnes, J., Lowery, M. H., Sierra, J., Pujol, M. V., Delgado, C., Gonzalez, P. J., Rodriguez, J. E., Bagno, L. L., Rouy, D., Altman, P., Foo, C. W., da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., & Hare, J. M. (2014). Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: The TAC-HFT randomized trial. Journal of the American Medical Association, 311(1), 62\u201373. https:\/\/doi.org\/10.1001\/jama.2013.282909","journal-title":"Journal of the American Medical Association"},{"issue":"6","key":"10765_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ahj.2011.01.028","volume":"161","author":"EC Perin","year":"2011","unstructured":"Perin, E. C., Silva, G. V., Henry, T. D., Cabreira-Hansen, M. G., Moore, W. H., Coulter, S. A., Herlihy, J. P., Fernandes, M. R., Cheong, B. Y., Flamm, S. D., Traverse, J. H., Zheng, Y., Smith, D., Shaw, S., Westbrook, L., Olson, R., Patel, D., Gahremanpour, A., Canales, J., Vaughn, W. K., & Willerson, J. T. (2011). A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). American Heart Journal, 161(6), 1078\u20131087e1073. https:\/\/doi.org\/10.1016\/j.ahj.2011.01.028","journal-title":"American Heart Journal"},{"issue":"3","key":"10765_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.yjmcc.2007.09.012","volume":"44","author":"EC Perin","year":"2008","unstructured":"Perin, E. C., Silva, G. V., Assad, J. A., Vela, D., Buja, L. M., Sousa, A. L., Litovsky, S., Lin, J., Vaughn, W. K., Coulter, S., Fernandes, M. R., & Willerson, J. T. (2008). Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 44(3), 486\u2013495. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.09.012","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10765_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2023.03.009","volume":"180","author":"C Chi","year":"2023","unstructured":"Chi, C., & Song, K. (2023). Cellular reprogramming of fibroblasts in heart regeneration. Journal of Molecular and Cellular Cardiology, 180, 84\u201393. https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.009","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"10","key":"10765_CR27","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.108.180588","volume":"103","author":"H Reinecke","year":"2008","unstructured":"Reinecke, H., Minami, E., Zhu, W. Z., & Laflamme, M. A. (2008). Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ Res, 103(10), 1058\u20131071. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.180588","journal-title":"Circ Res"},{"key":"10765_CR28","doi-asserted-by":"publisher","first-page":"101980","DOI":"10.1016\/j.arr.2023.101980","volume":"89","author":"M Ala","year":"2023","unstructured":"Ala, M. (2023). The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy. Ageing Research Reviews, 89, 101980. https:\/\/doi.org\/10.1016\/j.arr.2023.101980","journal-title":"Ageing Research Reviews"},{"issue":"12","key":"10765_CR29","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.26355\/eurrev_202106_26147","volume":"25","author":"B \u00d6zkaynak","year":"2021","unstructured":"\u00d6zkaynak, B., \u015eahin, I., \u00d6zenc, E., Suba\u015f\u0131, C., Oran, D. S., Totoz, T., Tetikkurt, \u00dc., Mert, S., Polat, B., Okuyan, A., E., & Kara\u00f6z, E. (2021). Mesenchymal stem cells derived from epicardial adipose tissue reverse cardiac remodeling in a rabbit model of myocardial infarction. European Review for Medical and Pharmacological Sciences, 25(12), 4372\u20134384. https:\/\/doi.org\/10.26355\/eurrev_202106_26147","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10765_CR30","doi-asserted-by":"publisher","first-page":"28250","DOI":"10.1038\/srep28250","volume":"6","author":"M Cai","year":"2016","unstructured":"Cai, M., Shen, R., Song, L., Lu, M., Wang, J., Zhao, S., Tang, Y., Meng, X., Li, Z., & He, Z. X. (2016). Bone marrow mesenchymal stem cells (BM-MSCs) improve heart function in Swine Myocardial Infarction Model through Paracrine effects. Scientific Reports, 6, 28250. https:\/\/doi.org\/10.1038\/srep28250","journal-title":"Scientific Reports"},{"issue":"7","key":"10765_CR31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1111\/jcmm.12287","volume":"18","author":"B Cai","year":"2014","unstructured":"Cai, B., Wang, G., Chen, N., Liu, Y., Yin, K., Ning, C., Li, X., Yang, F., Wang, N., Wang, Y., Pan, Z., & Lu, Y. (2014). Bone marrow mesenchymal stem cells protected post-infarcted myocardium against arrhythmias via reversing potassium channels remodelling. Journal of Cellular and Molecular Medicine, 18(7), 1407\u20131416. https:\/\/doi.org\/10.1111\/jcmm.12287","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"6","key":"10765_CR32","doi-asserted-by":"publisher","first-page":"e100982","DOI":"10.1371\/journal.pone.0100982","volume":"9","author":"VN Garikipati","year":"2014","unstructured":"Garikipati, V. N., Jadhav, S., Pal, L., Prakash, P., Dikshit, M., & Nityanand, S. (2014). Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: An in vivo serial pinhole gated SPECT-CT study in rats. PLoS One, 9(6), e100982. https:\/\/doi.org\/10.1371\/journal.pone.0100982","journal-title":"PLoS One"},{"issue":"1","key":"10765_CR33","doi-asserted-by":"publisher","first-page":"e10365","DOI":"10.1002\/btm2.10365","volume":"8","author":"X Liang","year":"2023","unstructured":"Liang, X., Zhang, Y., Lin, F., Li, M., Li, X., Chen, Y., Liu, J., Meng, Q., Ma, X., Wang, E., Wei, L., He, Z., Fan, H., Zhou, X., Ding, Y., & Liu, Z. (2023). Direct administration of mesenchymal stem cell-derived mitochondria improves cardiac function after infarction via ameliorating endothelial senescence. Bioeng Transl Med, 8(1), e10365. https:\/\/doi.org\/10.1002\/btm2.10365","journal-title":"Bioeng Transl Med"},{"issue":"8","key":"10765_CR34","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.bbadis.2017.02.023","volume":"1863","author":"N Wang","year":"2017","unstructured":"Wang, N., Chen, C., Yang, D., Liao, Q., Luo, H., Wang, X., Zhou, F., Yang, X., Yang, J., Zeng, C., & Wang, W. E. (2017). Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis. Biochim Biophys Acta Mol Basis Dis, 1863(8), 2085\u20132092. https:\/\/doi.org\/10.1016\/j.bbadis.2017.02.023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9","key":"10765_CR35","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/jcmm.13097","volume":"21","author":"QL Wang","year":"2017","unstructured":"Wang, Q. L., Wang, H. J., Li, Z. H., Wang, Y. L., Wu, X. P., & Tan, Y. Z. (2017). Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium. Journal of Cellular and Molecular Medicine, 21(9), 1751\u20131766. https:\/\/doi.org\/10.1111\/jcmm.13097","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"5","key":"10765_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s12265-013-9507-7","volume":"6","author":"SF Rodrigo","year":"2013","unstructured":"Rodrigo, S. F., van Ramshorst, J., Hoogslag, G. E., Boden, H., Velders, M. A., Cannegieter, S. C., Roelofs, H., Younis, A., Dibbets-Schneider, I., Fibbe, P., Zwaginga, W. E., Bax, J. J., Schalij, J. J., Beeres, M. J., S. L., & Atsma, D. E. (2013). Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. Journal of Cardiovascular Translational Research, 6(5), 816\u2013825. https:\/\/doi.org\/10.1007\/s12265-013-9507-7","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"4","key":"10765_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00395-012-0274-4","volume":"107","author":"F Wei","year":"2012","unstructured":"Wei, F., Wang, T. Z., Zhang, J., Yuan, Z. Y., Tian, H. Y., Ni, Y. J., Zhuo, X. Z., Han, K., Liu, Y., Lu, Q., Bai, H. Y., & Ma, A. Q. (2012). Mesenchymal stem cells neither fully acquire the electrophysiological properties of mature cardiomyocytes nor promote ventricular arrhythmias in infarcted rats. Basic Research in Cardiology, 107(4), 274. https:\/\/doi.org\/10.1007\/s00395-012-0274-4","journal-title":"Basic Research in Cardiology"},{"issue":"11","key":"10765_CR38","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1002\/jcp.29456","volume":"235","author":"X Liu","year":"2020","unstructured":"Liu, X., Li, X., Zhu, W., Zhang, Y., Hong, Y., Liang, X., Fan, B., Zhao, H., He, H., & Zhang, F. (2020). Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair. Journal of Cellular Physiology, 235(11), 8010\u20138022. https:\/\/doi.org\/10.1002\/jcp.29456","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10765_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12951-021-00808-5","volume":"19","author":"W Zhu","year":"2021","unstructured":"Zhu, W., Sun, L., Zhao, P., Liu, Y., Zhang, J., Zhang, Y., Hong, Y., Zhu, Y., Lu, Y., Zhao, W., Chen, X., & Zhang, F. (2021). Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p. J Nanobiotechnology, 19(1), 61. https:\/\/doi.org\/10.1186\/s12951-021-00808-5","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"10765_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/scrt425","volume":"5","author":"SL Zhao","year":"2014","unstructured":"Zhao, S. L., Zhang, Y. J., Li, M. H., Zhang, X. L., & Chen, S. L. (2014). Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction. Stem Cell Research & Therapy, 5(2), 37. https:\/\/doi.org\/10.1186\/scrt425","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"10765_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12015-022-10430-z","volume":"19","author":"P Zhou","year":"2023","unstructured":"Zhou, P., Yu, S. N., Zhang, H. F., Wang, Y. L., Tao, P., Tan, Y. Z., & Wang, H. J. (2023). c-kit(+)VEGFR-2(+) mesenchymal stem cells differentiate into Cardiovascular cells and repair infarcted myocardium after transplantation. Stem Cell Rev Rep, 19(1), 230\u2013247. https:\/\/doi.org\/10.1007\/s12015-022-10430-z","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"10765_CR42","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ultrasmedbio.2022.01.004","volume":"48","author":"W Wang","year":"2022","unstructured":"Wang, W., Tayier, B., Guan, L., Yan, F., & Mu, Y. (2022). Pre-transplantation of bone marrow mesenchymal stem cells amplifies the therapeutic effect of Ultrasound-targeted Microbubble Destruction-mediated localized combined gene therapy in Post-myocardial Infarction Heart failure rats. Ultrasound in Medicine and Biology, 48(5), 830\u2013845. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2022.01.004","journal-title":"Ultrasound in Medicine and Biology"},{"issue":"4","key":"10765_CR43","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3892\/mmr.2014.1923","volume":"9","author":"DG Wang","year":"2014","unstructured":"Wang, D. G., Zhang, F. X., Chen, M. L., Zhu, H. J., Yang, B., & Cao, K. J. (2014). Cx43 in mesenchymal stem cells promotes angiogenesis of the infarcted heart independent of gap junctions. Molecular Medicine Reports, 9(4), 1095\u20131102. https:\/\/doi.org\/10.3892\/mmr.2014.1923","journal-title":"Molecular Medicine Reports"},{"issue":"Pt A","key":"10765_CR44","doi-asserted-by":"publisher","first-page":"108180","DOI":"10.1016\/j.intimp.2021.108180","volume":"101","author":"L Jiang","year":"2021","unstructured":"Jiang, L., Yang, A., Li, X., Liu, K., & Tan, J. (2021). Down-regulation of VCAM-1 in bone mesenchymal stem cells reduces inflammatory responses and apoptosis to improve cardiac function in rat with myocardial infarction. International Immunopharmacology, 101(Pt A), 108180. https:\/\/doi.org\/10.1016\/j.intimp.2021.108180","journal-title":"International Immunopharmacology"},{"issue":"6","key":"10765_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00395-012-0301-5","volume":"107","author":"S Buccini","year":"2012","unstructured":"Buccini, S., Haider, K. H., Ahmed, R. P., Jiang, S., & Ashraf, M. (2012). Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart. Basic Research in Cardiology, 107(6), 301. https:\/\/doi.org\/10.1007\/s00395-012-0301-5","journal-title":"Basic Research in Cardiology"},{"issue":"3","key":"10765_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/FJC.0000000000000183","volume":"65","author":"D Dakhlallah","year":"2015","unstructured":"Dakhlallah, D., Zhang, J., Yu, L., Marsh, C. B., Angelos, M. G., & Khan, M. (2015). MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart. Journal of Cardiovascular Pharmacology, 65(3), 241\u2013251. https:\/\/doi.org\/10.1097\/FJC.0000000000000183","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1","key":"10765_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40824-023-00410-w","volume":"27","author":"W Zhu","year":"2023","unstructured":"Zhu, W., Wang, Q., Zhang, J., Sun, L., Hong, X., Du, W., Duan, R., Jiang, J., Ji, Y., Wang, H., & Han, B. (2023). Exosomes derived from mir-214-3p overexpressing mesenchymal stem cells promote myocardial repair. Biomater Res, 27(1), 77. https:\/\/doi.org\/10.1186\/s40824-023-00410-w","journal-title":"Biomater Res"},{"issue":"4","key":"10765_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tice.2010.04.004","volume":"42","author":"T Shu","year":"2010","unstructured":"Shu, T., Zeng, B., Ren, X., & Li, Y. (2010). HO-1 modified mesenchymal stem cells modulate MMPs\/TIMPs system and adverse remodeling in infarcted myocardium. Tissue and Cell, 42(4), 217\u2013222. https:\/\/doi.org\/10.1016\/j.tice.2010.04.004","journal-title":"Tissue and Cell"},{"issue":"8","key":"10765_CR49","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s11010-022-04628-5","volume":"478","author":"T Mustafa","year":"2023","unstructured":"Mustafa, T., Khan, I., Iqbal, H., Usman, S., Naeem, N., Faizi, S., & Salim, A. (2023). Rutin and quercetagetin enhance the regeneration potential of young and aging bone marrow-derived mesenchymal stem cells in the rat infarcted myocardium. Molecular and Cellular Biochemistry, 478(8), 1759\u20131770. https:\/\/doi.org\/10.1007\/s11010-022-04628-5","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"10765_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12951-021-01077-y","volume":"19","author":"H Zheng","year":"2021","unstructured":"Zheng, H., Liang, X., Han, Q., Shao, Z., Zhang, Y., Shi, L., Hong, Y., Li, W., Mai, C., Mo, Q., Fu, Q., Ma, X., Lin, F., Li, M., Hu, B., Li, X., & Zhang, Y. (2021). Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence. J Nanobiotechnology, 19(1), 332. https:\/\/doi.org\/10.1186\/s12951-021-01077-y","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"10765_CR51","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s12015-022-10499-6","volume":"19","author":"Y Pu","year":"2023","unstructured":"Pu, Y., Li, C., Qi, X., Xu, R., Dong, L., Jiang, Y., Gong, Q., Wang, D., Cheng, R., Zhang, C., & Chen, Y. (2023). Extracellular vesicles from NMN preconditioned mesenchymal stem cells ameliorated myocardial infarction via mir-210-3p promoted angiogenesis. Stem Cell Rev Rep, 19(4), 1051\u20131066. https:\/\/doi.org\/10.1007\/s12015-022-10499-6","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"10765_CR52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13287-022-02969-y","volume":"13","author":"Y Xiong","year":"2022","unstructured":"Xiong, Y., Tang, R., Xu, J., Jiang, W., Gong, Z., Zhang, L., Ning, Y., Huang, P., Xu, J., Chen, G., Li, X., Hu, M., Xu, J., Wu, C., Jin, C., Li, X., Qian, H., & Yang, Y. (2022). Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1\/NF-kappaB p65 pathway. Stem Cell Research & Therapy, 13(1), 289. https:\/\/doi.org\/10.1186\/s13287-022-02969-y","journal-title":"Stem Cell Research & Therapy"},{"issue":"5","key":"10765_CR53","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/jcmm.12036","volume":"17","author":"JL Carvalho","year":"2013","unstructured":"Carvalho, J. L., Braga, V. B., Melo, M. B., Campos, A. C., Oliveira, M. S., Gomes, D. A., Ferreira, A. J., Santos, R. A., & Goes, A. M. (2013). Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction. Journal of Cellular and Molecular Medicine, 17(5), 617\u2013625. https:\/\/doi.org\/10.1111\/jcmm.12036","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10765_CR54","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jss.2012.01.028","volume":"179","author":"E Fiumana","year":"2013","unstructured":"Fiumana, E., Pasquinelli, G., Foroni, L., Carboni, M., Bonafe, F., Orrico, C., Nardo, B., Tsivian, M., Neri, F., Arpesella, G., Guarnieri, C., Caldarera, C. M., & Muscari, C. (2013). Localization of mesenchymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart. Journal of Surgical Research, 179(1), e21\u201329. https:\/\/doi.org\/10.1016\/j.jss.2012.01.028","journal-title":"Journal of Surgical Research"},{"issue":"2","key":"10765_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvz139","volume":"116","author":"P Huang","year":"2020","unstructured":"Huang, P., Wang, L., Li, Q., Tian, X., Xu, J., Xu, J., Xiong, Y., Chen, G., Qian, H., Jin, C., Yu, Y., Cheng, K., Qian, L., & Yang, Y. (2020). Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res, 116(2), 353\u2013367. https:\/\/doi.org\/10.1093\/cvr\/cvz139","journal-title":"Cardiovasc Res"},{"key":"10765_CR56","doi-asserted-by":"publisher","unstructured":"Miller, M. A., & Zachary, J. F. (2017). Mechanisms and morphology of Cellular Injury, Adaptation, and death. 2\u201343.e19. https:\/\/doi.org\/10.1016\/b978-0-323-35775-3.00001-1","DOI":"10.1016\/b978-0-323-35775-3.00001-1"},{"issue":"4","key":"10765_CR57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12265-009-9137-2","volume":"2","author":"I Olivotto","year":"2009","unstructured":"Olivotto, I., Girolami, F., Nistri, S., Rossi, A., Rega, L., Garbini, F., Grifoni, C., Cecchi, F., & Yacoub, M. H. (2009). The many faces of hypertrophic cardiomyopathy: From developmental biology to clinical practice. Journal of Cardiovascular Translational Research, 2(4), 349\u2013367. https:\/\/doi.org\/10.1007\/s12265-009-9137-2","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"8","key":"10765_CR58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/hrt.2005.068270","volume":"93","author":"M Seddon","year":"2007","unstructured":"Seddon, M., Looi, Y. H., & Shah, A. M. (2007). Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart, 93(8), 903\u2013907. https:\/\/doi.org\/10.1136\/hrt.2005.068270","journal-title":"Heart"},{"key":"10765_CR59","doi-asserted-by":"publisher","first-page":"106607","DOI":"10.1016\/j.phrs.2022.106607","volume":"187","author":"Y Lu","year":"2023","unstructured":"Lu, Y., Zhang, J., Han, B., Yu, Y., Zhao, W., Wu, T., Mao, Y., & Zhang, F. (2023). Extracellular vesicles DJ-1 derived from hypoxia-conditioned hMSCs alleviate cardiac hypertrophy by suppressing mitochondria dysfunction and preventing ATRAP degradation. Pharmacological Research, 187, 106607. https:\/\/doi.org\/10.1016\/j.phrs.2022.106607","journal-title":"Pharmacological Research"},{"issue":"6","key":"10765_CR60","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1002\/ehf2.13065","volume":"7","author":"W Yu","year":"2020","unstructured":"Yu, W., Chen, C., & Cheng, J. (2020). The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy. ESC Heart Fail, 7(6), 3497\u20133504. https:\/\/doi.org\/10.1002\/ehf2.13065","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10765_CR61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/cbin.11482","volume":"45","author":"J Qiu","year":"2021","unstructured":"Qiu, J., Xiao, H., Zhou, S., Du, W., Mu, X., Shi, G., & Tan, X. (2021). Bone marrow mesenchymal stem cells inhibit cardiac hypertrophy by enhancing FoxO1 transcription. Cell Biology International, 45(1), 188\u2013197. https:\/\/doi.org\/10.1002\/cbin.11482","journal-title":"Cell Biology International"},{"key":"10765_CR62","doi-asserted-by":"publisher","first-page":"205031212096575","DOI":"10.1177\/2050312120965752","volume":"8","author":"MN Amin","year":"2020","unstructured":"Amin, M. N., Siddiqui, S. A., Ibrahim, M., Hakim, M. L., Ahammed, M. S., Kabir, A., & Sultana, F. (2020). Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer. SAGE Open Med, 8, 2050312120965752. https:\/\/doi.org\/10.1177\/2050312120965752","journal-title":"SAGE Open Med"},{"key":"10765_CR63","doi-asserted-by":"publisher","first-page":"738325","DOI":"10.3389\/fcvm.2021.738325","volume":"8","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y., Zhu, X., Cui, H., Shi, J., Yuan, G., Shi, S., & Hu, Y. (2021). The role of the VEGF family in Coronary Heart Disease. Front Cardiovasc Med, 8, 738325. https:\/\/doi.org\/10.3389\/fcvm.2021.738325","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"10765_CR64","doi-asserted-by":"publisher","first-page":"20597","DOI":"10.3390\/ijms141020597","volume":"14","author":"N Makki","year":"2013","unstructured":"Makki, N., Thiel, K. W., & Miller, F. J. Jr. (2013). The epidermal growth factor receptor and its ligands in cardiovascular disease. International Journal of Molecular Sciences, 14(10), 20597\u201320613. https:\/\/doi.org\/10.3390\/ijms141020597","journal-title":"International Journal of Molecular Sciences"},{"key":"10765_CR65","doi-asserted-by":"publisher","first-page":"8888575","DOI":"10.1155\/2021\/8888575","volume":"2021","author":"D Philipp","year":"2021","unstructured":"Philipp, D., Holthaus, M., Basoah, V., Pfannkuche, K., Suhr, L., Wahlers, T., & Paunel-Gorgulu, A. (2021). VEGF contributes to mesenchymal stem cell-mediated reversion of Nor1-Dependent hypertrophy in iPS Cell-Derived cardiomyocytes. Stem Cells Int, 2021, 8888575. https:\/\/doi.org\/10.1155\/2021\/8888575","journal-title":"Stem Cells Int"},{"issue":"1","key":"10765_CR66","doi-asserted-by":"publisher","first-page":"e20220221","DOI":"10.1590\/1678-4685-gmb-2022-0221","volume":"46","author":"Y Ren","year":"2023","unstructured":"Ren, Y., Wu, Y., He, W., Tian, Y., & Zhao, X. (2023). Exosomes secreted from bone marrow mesenchymal stem cells suppress cardiomyocyte hypertrophy through Hippo-YAP pathway in heart failure. Genet Mol Biol, 46(1), e20220221. https:\/\/doi.org\/10.1590\/1678-4685-gmb-2022-0221","journal-title":"Genet Mol Biol"},{"issue":"12","key":"10765_CR67","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.5966\/sctm.2015-0032","volume":"4","author":"B Cai","year":"2015","unstructured":"Cai, B., Tan, X., Zhang, Y., Li, X., Wang, X., Zhu, J., Wang, Y., Yang, F., Wang, B., Liu, Y., Xu, C., Pan, Z., Wang, N., Yang, B., & Lu, Y. (2015). Mesenchymal stem cells and cardiomyocytes interplay to prevent myocardial hypertrophy. Stem Cells Transl Med, 4(12), 1425\u20131435. https:\/\/doi.org\/10.5966\/sctm.2015-0032","journal-title":"Stem Cells Transl Med"},{"key":"10765_CR68","doi-asserted-by":"publisher","first-page":"111660","DOI":"10.1016\/j.intimp.2024.111660","volume":"129","author":"QM Huang","year":"2024","unstructured":"Huang, Q. M., Long, Y. L., Wang, J. N., Wu, J., Tang, W. L., Wang, X. Y., Zhang, Z. H., Zhuo, Y. Q., Guan, X. H., Deng, K. Y., & Xin, H. B. (2024). Human amniotic MSCs-mediated anti-inflammation of CD206(hi)IL-10(hi) macrophages alleviates isoproterenol-induced ventricular remodeling in mice. International Immunopharmacology, 129, 111660. https:\/\/doi.org\/10.1016\/j.intimp.2024.111660","journal-title":"International Immunopharmacology"},{"key":"10765_CR69","doi-asserted-by":"publisher","first-page":"204062232311687","DOI":"10.1177\/20406223231168755","volume":"14","author":"L Xie","year":"2023","unstructured":"Xie, L., Chen, J., Wang, Y., Jin, C., Xie, Y., Ma, H., & Xiang, M. (2023). Emerging roles of macrophages in heart failure and associated treatment approaches. Ther Adv Chronic Dis, 14, 20406223231168755. https:\/\/doi.org\/10.1177\/20406223231168755","journal-title":"Ther Adv Chronic Dis"},{"issue":"2","key":"10765_CR70","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jtcvs.2007.10.003","volume":"135","author":"EJ Molina","year":"2008","unstructured":"Molina, E. J., Palma, J., Gupta, D., Torres, D., Gaughan, J. P., Houser, S., & Macha, M. (2008). Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. Journal of Thoracic and Cardiovascular Surgery, 135(2), 292\u2013299. https:\/\/doi.org\/10.1016\/j.jtcvs.2007.10.003","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"issue":"2","key":"10765_CR71","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1440-1681.2008.05041.x","volume":"36","author":"RX Xu","year":"2009","unstructured":"Xu, R. X., Chen, X., Chen, J. H., Han, Y., & Han, B. M. (2009). Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms. Clinical and Experimental Pharmacology and Physiology, 36(2), 176\u2013180. https:\/\/doi.org\/10.1111\/j.1440-1681.2008.05041.x","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"2","key":"10765_CR72","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.stem.2017.07.011","volume":"21","author":"E El Agha","year":"2017","unstructured":"El Agha, E., Kramann, R., Schneider, R. K., Li, X., Seeger, W., Humphreys, B. D., & Bellusci, S. (2017). Mesenchymal stem cells in Fibrotic Disease. Cell Stem Cell, 21(2), 166\u2013177. https:\/\/doi.org\/10.1016\/j.stem.2017.07.011","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10765_CR73","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-020-01633-7","volume":"11","author":"L Jin","year":"2020","unstructured":"Jin, L., Zhang, J., Deng, Z., Liu, J., Han, W., Chen, G., Si, Y., & Ye, P. (2020). Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2. Stem Cell Research & Therapy, 11(1), 122. https:\/\/doi.org\/10.1186\/s13287-020-01633-7","journal-title":"Stem Cell Research & Therapy"},{"key":"10765_CR74","doi-asserted-by":"publisher","unstructured":"Li, K., Zhao, J., Wang, M., Niu, L., Wang, Y., Li, Y., & Zheng, Y. (2021). The roles of various prostaglandins in fibrosis: A review. Biomolecules, 11(6). https:\/\/doi.org\/10.3390\/biom11060789","DOI":"10.3390\/biom11060789"},{"issue":"2","key":"10765_CR75","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.yexcr.2016.10.022","volume":"349","author":"R Gallini","year":"2016","unstructured":"Gallini, R., Lindblom, P., Bondjers, C., Betsholtz, C., & Andrae, J. (2016). PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice. Experimental Cell Research, 349(2), 282\u2013290. https:\/\/doi.org\/10.1016\/j.yexcr.2016.10.022","journal-title":"Experimental Cell Research"},{"issue":"5","key":"10765_CR76","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jacbts.2022.01.004","volume":"7","author":"T Hamid","year":"2022","unstructured":"Hamid, T., Xu, Y., Ismahil, M. A., Rokosh, G., Jinno, M., Zhou, G., Wang, Q., & Prabhu, S. D. (2022). Cardiac mesenchymal stem cells promote fibrosis and remodeling in Heart failure: Role of PDGF Signaling. JACC Basic Transl Sci, 7(5), 465\u2013483. https:\/\/doi.org\/10.1016\/j.jacbts.2022.01.004","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"10765_CR77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.stem.2021.10.009","volume":"29","author":"V Janbandhu","year":"2022","unstructured":"Janbandhu, V., Tallapragada, V., Patrick, R., Li, Y., Abeygunawardena, D., Humphreys, D. T., Martin, E., Ward, A. O., Contreras, O., Farbehi, N., Yao, E., Du, J., Dunwoodie, S. L., Bursac, N., & Harvey, R. P. (2022). Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction. Cell Stem Cell, 29(2), 281\u2013297e212. https:\/\/doi.org\/10.1016\/j.stem.2021.10.009","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10765_CR78","doi-asserted-by":"publisher","first-page":"348","DOI":"10.21037\/cdt-20-1032","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu, J., Chen, X., Li, P., Lu, X., Yan, J., Tan, H., & Zhang, C. (2021). Exosomes derived from human amniotic fluid mesenchymal stem cells alleviate cardiac fibrosis via enhancing angiogenesis in vivo and in vitro. Cardiovasc Diagn Ther, 11(2), 348\u2013361. https:\/\/doi.org\/10.21037\/cdt-20-1032","journal-title":"Cardiovasc Diagn Ther"},{"key":"10765_CR79","doi-asserted-by":"publisher","unstructured":"Fikry, E. M., Hassan, W. A., & Gad, A. M. (2017). Bone marrow and adipose mesenchymal stem cells attenuate cardiac fibrosis induced by methotrexate in rats. Journal of Biochemical and Molecular Toxicology, 31(11). https:\/\/doi.org\/10.1002\/jbt.21970","DOI":"10.1002\/jbt.21970"},{"key":"10765_CR80","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.omtn.2021.10.013","volume":"26","author":"N Zeng","year":"2021","unstructured":"Zeng, N., Huang, Y. Q., Yan, Y. M., Hu, Z. Q., Zhang, Z., Feng, J. X., Guo, J. S., Zhu, J. N., Fu, Y. H., Wang, X. P., Zhang, M. Z., Duan, J. Z., Zheng, X. L., Xu, J. D., & Shan, Z. X. (2021). Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis. Mol Ther Nucleic Acids, 26, 1035\u20131050. https:\/\/doi.org\/10.1016\/j.omtn.2021.10.013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"10765_CR81","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11626-020-00481-2","volume":"56","author":"F Chen","year":"2020","unstructured":"Chen, F., Li, X., Zhao, J., Geng, J., Xie, J., & Xu, B. (2020). Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling. In Vitro Cellular and Developmental Biology. Animal, 56(7), 567\u2013576. https:\/\/doi.org\/10.1007\/s11626-020-00481-2","journal-title":"In Vitro Cellular and Developmental Biology. Animal"},{"key":"10765_CR82","doi-asserted-by":"publisher","unstructured":"Ali, S. A., & Singla, D. K. (2024). Mesenchymal stem cell-derived Exosomes Ameliorate Doxorubicin-Induced Cardiotoxicity. Pharmaceuticals (Basel), 17(1). https:\/\/doi.org\/10.3390\/ph17010093","DOI":"10.3390\/ph17010093"},{"issue":"2","key":"10765_CR83","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3892\/ijmm.2014.1782","volume":"34","author":"X Yi","year":"2014","unstructured":"Yi, X., Li, X., Zhou, Y., Ren, S., Wan, W., Feng, G., & Jiang, X. (2014). Hepatocyte growth factor regulates the TGF-\u03b21-induced proliferation, differentiation and secretory function of cardiac fibroblasts. International Journal of Molecular Medicine, 34(2), 381\u2013390. https:\/\/doi.org\/10.3892\/ijmm.2014.1782","journal-title":"International Journal of Molecular Medicine"},{"key":"10765_CR84","doi-asserted-by":"publisher","first-page":"33700","DOI":"10.1038\/srep33700","volume":"6","author":"H Chen","year":"2016","unstructured":"Chen, H., Xia, R., Li, Z., Zhang, L., Xia, C., Ai, H., Yang, Z., & Guo, Y. (2016). Mesenchymal stem cells combined with hepatocyte growth factor therapy for attenuating ischaemic myocardial fibrosis: Assessment using Multimodal Molecular Imaging. Scientific Reports, 6, 33700. https:\/\/doi.org\/10.1038\/srep33700","journal-title":"Scientific Reports"},{"issue":"12","key":"10765_CR85","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1432-2277.2008.00742.x","volume":"21","author":"L Li","year":"2008","unstructured":"Li, L., Zhang, Y., Li, Y., Yu, B., Xu, Y., Zhao, S., & Guan, Z. (2008). Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transplant International, 21(12), 1181\u20131189. https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00742.x","journal-title":"Transplant International"},{"issue":"5","key":"10765_CR86","doi-asserted-by":"publisher","first-page":"303","DOI":"10.14744\/AnatolJCardiol.2020.54937","volume":"24","author":"\u00d6 \u00c7elik","year":"2020","unstructured":"\u00c7elik, \u00d6., \u015eahin, A. A., Sar\u0131kaya, S., & Uygur, B. (2020). Correlation between serum matrix metalloproteinase and myocardial fibrosis in heart failure patients with reduced ejection fraction: A retrospective analysis. Anatol J Cardiol, 24(5), 303\u2013308. https:\/\/doi.org\/10.14744\/AnatolJCardiol.2020.54937","journal-title":"Anatol J Cardiol"},{"issue":"11","key":"10765_CR87","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/stem.169","volume":"27","author":"C Mias","year":"2009","unstructured":"Mias, C., Lairez, O., Trouche, E., Roncalli, J., Calise, D., Seguelas, M. H., Ordener, C., Piercecchi-Marti, M. D., Auge, N., Salvayre, A. N., Bourin, P., Parini, A., & Cussac, D. (2009). Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells, 27(11), 2734\u20132743. https:\/\/doi.org\/10.1002\/stem.169","journal-title":"Stem Cells"},{"issue":"2","key":"10765_CR88","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.rbmo.2022.05.018","volume":"46","author":"X Li","year":"2023","unstructured":"Li, X., Duan, H., Wang, S., & Lv, C. X. (2023). Umbilical cord mesenchymal stem cell-derived exosomes reverse endometrial fibrosis by the miR-145-5p\/ZEB2 axis in intrauterine adhesions. Reproductive Biomedicine Online, 46(2), 234\u2013243. https:\/\/doi.org\/10.1016\/j.rbmo.2022.05.018","journal-title":"Reproductive Biomedicine Online"},{"issue":"3","key":"10765_CR89","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ijcard.2014.09.128","volume":"177","author":"S Roura","year":"2014","unstructured":"Roura, S., Galvez-Monton, C., & Bayes-Genis, A. (2014). Umbilical cord blood-derived mesenchymal stem cells: New therapeutic weapons for idiopathic dilated cardiomyopathy? International Journal of Cardiology, 177(3), 809\u2013818. https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.128","journal-title":"International Journal of Cardiology"},{"key":"10765_CR90","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.reth.2021.06.006","volume":"18","author":"D Mori","year":"2021","unstructured":"Mori, D., Miyagawa, S., Kido, T., Hata, H., Ueno, T., Toda, K., Kuratani, T., Oota, M., Kawai, K., Kurata, H., Nishida, H., & Sawa, Y. (2021). Adipose-derived mesenchymal stem cells preserve cardiac function via ANT-1 in dilated cardiomyopathy hamster model. Regen Ther, 18, 182\u2013190. https:\/\/doi.org\/10.1016\/j.reth.2021.06.006","journal-title":"Regen Ther"},{"key":"10765_CR91","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.tvjl.2015.11.009","volume":"209","author":"PD Morschbacher","year":"2016","unstructured":"Morschbacher, P. D., Garcez, A., Paz, T. N., Magrisso, A. H., Mello, A. B., Rolim, H. F., Neuwald, V. M., Driemeier, E. B., Contesini, D., E. A., & Cirne-Lima, E. (2016). Treatment of dilated cardiomyopathy in rabbits with mesenchymal stem cell transplantation and platelet-rich plasma. The Veterinary Journal, 209, 180\u2013185. https:\/\/doi.org\/10.1016\/j.tvjl.2015.11.009","journal-title":"The Veterinary Journal"},{"issue":"5","key":"10765_CR92","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5761\/atcs.oa.13-00104","volume":"20","author":"L Li","year":"2014","unstructured":"Li, L., & Xia, Y. (2014). Study of adipose tissue-derived mesenchymal stem cells transplantation for rats with dilated cardiomyopathy. Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 20(5), 398\u2013406. https:\/\/doi.org\/10.5761\/atcs.oa.13-00104","journal-title":"Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia"},{"issue":"1\u20132","key":"10765_CR93","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11010-013-1894-1","volume":"387","author":"Q Yu","year":"2014","unstructured":"Yu, Q., Li, Q., Na, R., Li, X., Liu, B., Meng, L., Liutong, H., Fang, W., Zhu, N., & Zheng, X. (2014). Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy. Molecular and Cellular Biochemistry, 387(1\u20132), 279\u2013285. https:\/\/doi.org\/10.1007\/s11010-013-1894-1","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10765_CR94","doi-asserted-by":"publisher","first-page":"116159","DOI":"10.1016\/j.biopha.2024.116159","volume":"171","author":"J Zhang","year":"2024","unstructured":"Zhang, J., Cheng, L., Li, Z., Li, H., Liu, Y., Zhan, H., Xu, H., Huang, Y., Feng, F., & Li, Y. (2024). Immune cells and related cytokines in dilated cardiomyopathy. Biomedicine & Pharmacotherapy, 171, 116159. https:\/\/doi.org\/10.1016\/j.biopha.2024.116159","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10765_CR95","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13287-022-03101-w","volume":"13","author":"C Gong","year":"2022","unstructured":"Gong, C., Chang, L., Sun, X., Qi, Y., Huang, R., Chen, K., Wang, B., Kang, L., Wang, L., & Xu, B. (2022). Infusion of two-dose mesenchymal stem cells is more effective than a single dose in a dilated cardiomyopathy rat model by upregulating indoleamine 2,3-dioxygenase expression. Stem Cell Research & Therapy, 13(1), 409. https:\/\/doi.org\/10.1186\/s13287-022-03101-w","journal-title":"Stem Cell Research & Therapy"},{"issue":"4","key":"10765_CR96","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.bbrc.2019.07.053","volume":"517","author":"H Lin","year":"2019","unstructured":"Lin, H., Ling, Y., Pan, J., & Gong, H. (2019). Therapeutic effects of erythropoietin expressed in mesenchymal stem cells for dilated cardiomyopathy in rat. Biochemical and Biophysical Research Communications, 517(4), 575\u2013580. https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.053","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10765_CR97","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.bbrc.2018.08.012","volume":"503","author":"X Sun","year":"2018","unstructured":"Sun, X., Shan, A., Wei, Z., & Xu, B. (2018). Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy. Biochemical and Biophysical Research Communications, 503(4), 2611\u20132618. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.012","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10765_CR98","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.yexmp.2009.12.002","volume":"88","author":"Y Chen","year":"2010","unstructured":"Chen, Y., Liu, W., Li, W., & Gao, C. (2010). Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy. Experimental and Molecular Pathology, 88(2), 311\u2013315. https:\/\/doi.org\/10.1016\/j.yexmp.2009.12.002","journal-title":"Experimental and Molecular Pathology"},{"issue":"4","key":"10765_CR99","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"M Dobaczewski","year":"2011","unstructured":"Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011). Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. Journal of Molecular and Cellular Cardiology, 51(4), 600\u2013606. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.10.033","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"17","key":"10765_CR100","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1093\/hmg\/ddy215","volume":"27","author":"M Chatzifrangkeskou","year":"2018","unstructured":"Chatzifrangkeskou, M., Yadin, D., Marais, T., Chardonnet, S., Cohen-Tannoudji, M., Mougenot, N., Schmitt, A., Crasto, S., Di Pasquale, E., Macquart, C., Tanguy, Y., Jebeniani, I., Puc\u00e9at, M., Rodriguez, M., Goldmann, B., Dal Ferro, W. H., Biferi, M., Knaus, M. G., Bonne, P., Worman, G., H. J., & Muchir, A. (2018). Cofilin-1 phosphorylation catalyzed by ERK1\/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A\/C gene mutation. Human Molecular Genetics, 27(17), 3060\u20133078. https:\/\/doi.org\/10.1093\/hmg\/ddy215","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10765_CR101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/mmr.2017.7882","volume":"17","author":"C Zhang","year":"2018","unstructured":"Zhang, C., Zhou, G., Chen, Y., Liu, S., Chen, F., Xie, L., Wang, W., Zhang, Y., Wang, T., Lai, X., & Ma, L. (2018). Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF\u2013alpha and TGF\u2013beta1\/ERK1\/2 signaling pathways. Molecular Medicine Reports, 17(1), 71\u201378. https:\/\/doi.org\/10.3892\/mmr.2017.7882","journal-title":"Molecular Medicine Reports"},{"issue":"8","key":"10765_CR102","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.104.500447","volume":"112","author":"N Nagaya","year":"2005","unstructured":"Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., Fujii, T., Uematsu, M., Ohgushi, H., Yamagishi, M., Tokudome, T., Mori, H., Miyatake, K., & Kitamura, S. (2005). Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 112(8), 1128\u20131135. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.500447","journal-title":"Circulation"},{"issue":"1","key":"10765_CR103","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejcb.2015.11.003","volume":"95","author":"X Gong","year":"2016","unstructured":"Gong, X., Wang, P., Wu, Q., Wang, S., Yu, L., & Wang, G. (2016). Human umbilical cord blood derived mesenchymal stem cells improve cardiac function in cTnT(R141W) transgenic mouse of dilated cardiomyopathy. European Journal of Cell Biology, 95(1), 57\u201367. https:\/\/doi.org\/10.1016\/j.ejcb.2015.11.003","journal-title":"European Journal of Cell Biology"},{"issue":"13","key":"10765_CR104","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/cvr\/cvaa004","volume":"116","author":"V Florea","year":"2020","unstructured":"Florea, V., Rieger, A. C., Natsumeda, M., Tompkins, B. A., Banerjee, M. N., Schulman, I. H., Premer, C., Khan, A., Valasaki, K., Heidecker, B., Mantero, A., Balkan, W., Mitrani, R. D., & Hare, J. M. (2020). The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathy. Cardiovasc Res, 116(13), 2131\u20132141. https:\/\/doi.org\/10.1093\/cvr\/cvaa004","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10765_CR105","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/s1472-6483(10)60159-9","volume":"16","author":"TE Ichim","year":"2008","unstructured":"Ichim, T. E., Solano, F., Brenes, R., Glenn, E., Chang, J., Chan, K., & Riordan, N. H. (2008). Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reproductive Biomedicine Online, 16(6), 898\u2013905. https:\/\/doi.org\/10.1016\/s1472-6483(10)60159-9","journal-title":"Reproductive Biomedicine Online"},{"key":"10765_CR106","doi-asserted-by":"publisher","first-page":"105884","DOI":"10.1016\/j.biocel.2020.105884","volume":"130","author":"H Ling","year":"2021","unstructured":"Ling, H., Guo, Z., Tan, L., Cao, Q., & Song, C. (2021). Stem cell-derived exosomes: Role in the pathogenesis and treatment of atherosclerosis. International Journal of Biochemistry & Cell Biology, 130, 105884. https:\/\/doi.org\/10.1016\/j.biocel.2020.105884","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"7","key":"10765_CR107","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2174\/1574888x16999210128193549","volume":"16","author":"V Ogay","year":"2021","unstructured":"Ogay, V., Sekenova, A., Li, Y., Issabekova, A., & Saparov, A. (2021). The therapeutic potential of mesenchymal stem cells in the treatment of atherosclerosis. Curr Stem Cell Res Ther, 16(7), 897\u2013913. https:\/\/doi.org\/10.2174\/1574888x16999210128193549","journal-title":"Curr Stem Cell Res Ther"},{"key":"10765_CR108","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fcvm.2017.00032","volume":"4","author":"F Li","year":"2017","unstructured":"Li, F., Guo, X., & Chen, S. Y. (2017). Function and therapeutic potential of mesenchymal stem cells in atherosclerosis. Front Cardiovasc Med, 4, 32. https:\/\/doi.org\/10.3389\/fcvm.2017.00032","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10765_CR109","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbrc.2019.02.005","volume":"510","author":"J Li","year":"2019","unstructured":"Li, J., Xue, H., Li, T., Chu, X., Xin, D., Xiong, Y., Qiu, W., Gao, X., Qian, M., Xu, J., Wang, Z., & Li, G. (2019). Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE(-\/-) mice via miR-let7 mediated infiltration and polarization of M2 macrophage. Biochemical and Biophysical Research Communications, 510(4), 565\u2013572. https:\/\/doi.org\/10.1016\/j.bbrc.2019.02.005","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10765_CR110","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trsl.2020.07.003","volume":"226","author":"Z Guo","year":"2020","unstructured":"Guo, Z., Zhao, Z., Yang, C., & Song, C. (2020). Transfer of microRNA-221 from mesenchymal stem cell-derived extracellular vesicles inhibits atherosclerotic plaque formation. Translational Research : The Journal of Laboratory and Clinical Medicine, 226, 83\u201395. https:\/\/doi.org\/10.1016\/j.trsl.2020.07.003","journal-title":"Translational Research : The Journal of Laboratory and Clinical Medicine"},{"key":"10765_CR111","doi-asserted-by":"publisher","first-page":"120810","DOI":"10.1016\/j.biomaterials.2021.120810","volume":"273","author":"DD Chin","year":"2021","unstructured":"Chin, D. D., Poon, C., Wang, J., Joo, J., Ong, V., Jiang, Z., Cheng, K., Plotkin, A., Magee, G. A., & Chung, E. J. (2021). miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype. Biomaterials, 273, 120810. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120810","journal-title":"Biomaterials"},{"key":"10765_CR112","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.omtn.2020.10.037","volume":"23","author":"W Yang","year":"2021","unstructured":"Yang, W., Yin, R., Zhu, X., Yang, S., Wang, J., Zhou, Z., Pan, X., & Ma, A. (2021). Mesenchymal stem-cell-derived exosomal miR-145 inhibits atherosclerosis by targeting JAM-A. Mol Ther Nucleic Acids, 23, 119\u2013131. https:\/\/doi.org\/10.1016\/j.omtn.2020.10.037","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"10765_CR113","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1152\/physrev.00009.2023","volume":"104","author":"S Barr\u00e8re-Lemaire","year":"2024","unstructured":"Barr\u00e8re-Lemaire, S., Vincent, A., Jorgensen, C., Piot, C., Nargeot, J., & Djouad, F. (2024). Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: A matter of timing. Physiological Reviews, 104(2), 659\u2013725. https:\/\/doi.org\/10.1152\/physrev.00009.2023","journal-title":"Physiological Reviews"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10765-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-024-10765-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10765-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T10:17:32Z","timestamp":1727777852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-024-10765-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10765"],"URL":"https:\/\/doi.org\/10.1007\/s12015-024-10765-9","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"11 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"I approve this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"I agree to publish the current study in this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"I declare that I have no known competing financial interests or personal relationships.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}